A Single Intravitreal Injection of rAAV2-ND4 for the Treatment of Leber's Hereditary Optic Neuropathy

NCT03153293 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

159

Enrollment

OTHER

Sponsor class

Conditions

Leber Hereditary Optic Neuropathy

Interventions

DRUG: rAAV2-ND4

Sponsor

Huazhong University of Science and Technology

Collaborators

[object Object]